Status:
NOT_YET_RECRUITING
Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, Without Compromising the Quality of Colonoscopy? An International Multi-centre Randomized Controlled Trial.
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Bowel Preparation Quality
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The goal of this study is to assess the clinical and cost-effectiveness of the AI bowel preparation evaluation system in reducing the consumption volume of the standard high-volume PEG regimen before ...
Detailed Description
Colonoscopy is the gold standard for screening colorectal cancer (CRC), which is the third most common cancer and the second leading cause of cancer-related mortality worldwide. Polypectomy during scr...
Eligibility Criteria
Inclusion
- individual aged 65 years or above
- undergoing colonoscopy for any indication
- requiring a standard high-volume PEG regimen for bowel preparation
- having a smartphone themselves or their caregivers (including ward nurses) having one will be recruited.
Exclusion
- allergy to PEG,
- suspected or diagnosed gastrointestinal obstruction or perforation,
- suspected or diagnosed ileus
- suspected or diagnosed gastric retention
- suspected or diagnosed toxic colitis, toxic megacolon,
- prior gastrointestinal surgery, and
- unable to provide informed consent.
Key Trial Info
Start Date :
June 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2028
Estimated Enrollment :
1824 Patients enrolled
Trial Details
Trial ID
NCT06904209
Start Date
June 1 2026
End Date
June 30 2028
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre of Digestive Health
Hong Kong, Hong Kong